ProCE Banner Activity

Changing TKIs Due To CML Progression: Second-Line Therapy and Future Options

Slideset Download
Downloadable slides with expert analysis of second-line treatment of CP CML with TKIs after disease progression.

Released: July 08, 2020

Expiration: July 07, 2021

No longer available for credit.

Share

Faculty

Jorge Cortes

Jorge Cortes, MD

Professor of Medicine
Deputy Chair, Department of Leukemia
M.D. Anderson Cancer Center
Houston, Texas

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Pfizer, Inc.

Faculty Disclosure

Primary Author

Jorge Cortes, MD

Professor of Medicine
Deputy Chair, Department of Leukemia
M.D. Anderson Cancer Center
Houston, Texas